Bruce D. Jackson
Stock Analyst at Benchmark
(2.85)
# 1,809
Out of 5,045 analysts
4
Total ratings
75%
Success rate
21.69%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Bruce D. Jackson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RVPH Reviva Pharmaceuticals Holdings | Maintains: Speculative Buy | $14 → $7 | $0.60 | +1,071.94% | 1 | Sep 15, 2025 | |
| UNCY Unicycive Therapeutics | Maintains: Speculative Buy | $3 → $21 | $4.76 | +341.18% | 1 | Sep 15, 2025 | |
| HBIO Harvard Bioscience | Maintains: Speculative Buy | $3 → $2 | $0.53 | +277.36% | 1 | Sep 10, 2025 | |
| CLNN Clene | Maintains: Buy | $33 → $31 | $10.32 | +200.39% | 1 | Sep 10, 2025 |
Reviva Pharmaceuticals Holdings
Sep 15, 2025
Maintains: Speculative Buy
Price Target: $14 → $7
Current: $0.60
Upside: +1,071.94%
Unicycive Therapeutics
Sep 15, 2025
Maintains: Speculative Buy
Price Target: $3 → $21
Current: $4.76
Upside: +341.18%
Harvard Bioscience
Sep 10, 2025
Maintains: Speculative Buy
Price Target: $3 → $2
Current: $0.53
Upside: +277.36%
Clene
Sep 10, 2025
Maintains: Buy
Price Target: $33 → $31
Current: $10.32
Upside: +200.39%